Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 3, 2011, Pages

  McCarthy, Fergus P ^a   Giles, Michelle L ^b   Rowlands, Shelley ^b   Purcell, Kara J ^c   Jones, Cheryl A ^d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c Irish Centre for Fetal and Neonatal Translational Research   (Ireland)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOMEGALOVIRUS VACCINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT;

ADVERSE OUTCOME; ANTIVIRAL THERAPY; ARTICLE; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOTHERAPY; INFANT DISEASE; INFECTION PREVENTION; MOTHER; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VACCINATION; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FEMALE; FETUS DISEASE; PREGNANCY COMPLICATION; REVIEW; VERTICAL TRANSMISSION; VIROLOGY;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

EID: 79953267829     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008371.pub2     Document Type: Article

References (37)

1. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatric Infectious Disease Journal 1996;15(3):240-6. [PUBMED: 8852913]
2. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. Journal of Pediatrics 2004;145(4):485-91.
3. Jiang H, Chen SH, Wen LZ. Effects of Jinye Baidu granule on fetal growth and development with maternal active human cytomegalovirus infection. Chinese Journal of Integrative Medicine 2006;12(4):250-4.
4. Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. New England Journal of Medicine 2005;29(353):1350-62. [PUBMED: 16192480]
5. Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, et al.Vaccine prevention of maternal cytomegalovirus infection. New England Journal of Medicine 2009;360(12):1191-9.
6. Picone O, Vauloup-Fellous C, Cordier AG, Parent Du Châtelet I, Senat MV, Frydman R, et al.A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. British Journal of Obstetrics and Gynaecology 2009 May;116(6):818-23. [PUBMED: 19432571]
7. Acosta EP, Brundage RC, King JR, Sánchez PJ, Sood S, Agrawal V, et al.Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clinical and Pharmacology and Therapeutics 2007;81(6):867-72.
8. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Reviews of Infectious Diseases 1990;12 Suppl 7:S745-S753. [MEDLINE: 2173104]
9. Anon. Knowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy-United States, 2007. MMWR: Morbidity and Mortality Weekly Report 2008; 57(3):65-8. [PUBMED: 18219267]
10. Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstetrics & Gynecology 1999;93(5 Pt 1):658-60. [MEDLINE: 10912962;: 0029-7844 (Print)]
11. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. Journal of Infectious Diseases 1995;171(5):1115-21. [PUBMED: 7751685]
12. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005;5:70. [PUBMED: 15967030]
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315(7109): 629-34.
14. Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990;39(4):597-638.
15. Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. Journal of Virology 2000;74(15):6808-20. [MEDLINE: 10888620;: 0022-538X (Print)]
16. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003;289(8): 1008-11. [MEDLINE: 12597753]
17. Fowler KB, Stagno S, Pass RF. Interval between births and risk of congenital cytomegalovirus infection. Clinical Infectious Diseases 2004;38(7):1035-7. [MEDLINE: 15034839]
18. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstetrical and Gynecological Survey 2002;57(4):245-56. [MEDLINE: 11961482]
19. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443-57.
20. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochranehandbook.org.
21. Ho M. Epidemiology of cytomegalovirus infections. Reviews of Infectious Diseases 1990;12(7):S701-S710. [PUBMED: 2173099]
22. Jeon J, Victor M, Adler SP, Arwady A, Demmler G, Fowler K, et al.Knowledge and awareness of congenital cytomegalovirus among women. Infectious Diseases in Obstetrics and Gynecology 2006;2006: 80383.
23. Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, et al.Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. Journal of Pediatrics 2003;143(1):16-25.
24. Kumar ML, Nankervis GA, Jacobs IB, Ernhart CB, Glasson CE, McMillan PM, et al.Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up. Journal of Pediatrics 1984;104(5):674-9. [PUBMED: 6325654]
25. Lazzarotto T, Varani S, Gabrielli L, Spezzacatena P, Landini MP. New advances in the diagnosis of congenital cytomegalovirus infection. Intervirology 1999;42(5-6):390-7. [MEDLINE: 10702722]
26. McIver CJ, Jacques CF, Chow SS, Munro SC, Scott GM, Roberts JA, et al.Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections. Journal of Clinical Microbiology 2005;43(10):5102-10. [MEDLINE: 16207970]
27. Raynor BD. Cytomegalovirus infection in pregnancy. Seminars in Perinatology 1993;17(6):394-402. [MEDLINE: 8160023;: 0146-0005 (Print)]
28. Revello MG. Prevention of human cytomegalovirus (HCMV) mother-to-fetus transmission by administration of virus-specific hyperimmune globulin to pregnant women With primary HCMV infection. http://clinicaltrials.gov/ct2/show/record/NCT00881517 (accessed 1 June 2010).
29. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
30. Schleiss MR. Role of breast milk in acquisition of cytomegalovirus infection: recent advances. Current Opinion in Pediatrics 2006 Feb; 18(1):48-52. [PUBMED: 16470162]
31. Schleiss MR. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. Journal of Clinical Virology 2008;41(3):224-30. [PUBMED: 18060834 ]
32. Schleiss M. Cytomegalovirus vaccines: at last, a major step forward. Herpes 2009;15(3):44-5. [PUBMED: 19306601]
33. Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, et al.Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. New England Journal of Medicine 1987;317(17):1049-54.
34. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, Walton PD, et al.Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. New England Journal of Medicine 1982;306(16):945-9. [PUBMED: 6278309]
35. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. New England Journal of Medicine 1985;313(20):1270-4. [MEDLINE: 2997607]
36. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, et al.Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256(14): 1904-8. [MEDLINE: 3020264]
37. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical Infectious Diseases 2006;43(9): 1143-51. [PUBMED: 17029132]